Published in Restor Neurol Neurosci on January 01, 1998
The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury. Restor Neurol Neurosci (2007) 0.82
Study of epileptiform activity in cerebral ganglion of mud crab Scylla serrata. Invert Neurosci (2011) 0.76
Anticonvulsant drugs, brain glutamate dehydrogenase activity and oxygen consumption. ISRN Pharmacol (2012) 0.76
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. Oncotarget (2016) 0.75
Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res (1983) 2.46
Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse (1989) 2.23
Seizures produced by pilocarpine in mice: a behavioral, electroencephalographic and morphological analysis. Brain Res (1984) 1.59
Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia (1992) 1.57
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand (2003) 1.51
The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res (1987) 1.20
Cholinomimetics produce seizures and brain damage in rats. Experientia (1983) 1.18
Neuroprotective role of testosterone in the nervous system. Pol J Pharmacol (2004) 1.14
Synthesis, chemical and pharmacological properties of some N-aminoalkyl derivatives of 3,4-pyridinedicarboxamides. Farmaco (1995) 1.06
Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.06
The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. Pol J Pharmacol Pharm (1989) 1.02
Age-related changes in kynurenic acid production in rat brain. Brain Res (1992) 1.00
In vitro release and electrophysiological effects in situ of homocysteic acid, an endogenous N-methyl-(D)-aspartic acid agonist, in the mammalian striatum. J Neurosci (1986) 1.00
Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience (1986) 0.99
Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia (2000) 0.99
Micromolar concentration of kynurenic acid in rat small intestine. Amino Acids (2008) 0.96
2-Substituted-3-oxoisothiazolo[5,4-b]pyridines as potential central nervous system and antimycobacterial agents. Farmaco (1998) 0.95
Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci Lett (1985) 0.94
Muscle relaxant action of excitatory amino acid antagonists. Neurosci Lett (1985) 0.92
Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res (1987) 0.92
Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem (1997) 0.91
Biological properties and clinical application of propolis. X. Preliminary pharmacological evaluation of ethanol extract of propolis (EEP). Arzneimittelforschung (1978) 0.89
Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximides. Farmaco (1999) 0.89
Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol (1982) 0.89
Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. Proc Natl Acad Sci U S A (1987) 0.89
Tryptophan-kynurenine metabolism and insulin resistance in hepatitis C patients. Hepat Res Treat (2013) 0.89
Convulsant action of morphine, [D-Ala2, D-Leu5]-enkephalin and naloxone in the rat amygdala: electroencephalographic, morphological and behavioural sequelae. Neuroscience (1987) 0.88
Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp Neurol (1986) 0.87
AMPA and GABA(B) receptor antagonists and their interaction in rats with a genetic form of absence epilepsy. Eur J Pharmacol (2001) 0.87
Seizures produced by pilocarpine: neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res (1986) 0.87
Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or gamma-vinyl-GABA into the substantia nigra. Brain Res (1986) 0.86
Substantia nigra: a site of action of muscle relaxant drugs. Ann Neurol (1990) 0.86
Two essential amino acids, L-lysine and L-histidine, in five types of experimental seizures. Pol J Pharmacol (2001) 0.85
Effects of pentagastrin and oxyphenonium on the levels of serotonin and 5-hydroxyindoleacetic acid in different parts of the digestive tract, blood and brain of rats. Acta Physiol Pol (1986) 0.85
Antagonism of N-methyl-D,L-aspartic acid-induced convulsions by antiepileptic drugs and other agents. Eur J Pharmacol (1985) 0.85
GABA content and GAD activity in gastric cancer. Med Sci Monit (2001) 0.85
Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology (1990) 0.84
Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: an electroencephalographic, behavioural and morphological analysis. Neuroscience (1985) 0.84
Anticonvulsant activity of carbamazepine and diphenylhydantoin against maximal electroshock in mice chronically treated with aminophylline. J Neural Transm Gen Sect (1992) 0.84
A comparison of the anticonvulsant potency of (+/-) 2-amino-5-phosphonopentanoic acid and (+/-) 2-amino-7-phosphonoheptanoic acid. Neuroscience (1983) 0.83
Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur J Pharmacol (1997) 0.83
Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology (1990) 0.83
Effect of topiramate on the kainate-induced status epilepticus, lipid peroxidation and immunoreactivity of rats. Pol J Pharmacol (2004) 0.83
Some central effects of diethyldithiocarbamate administered intraventricularly in rats. Neuropharmacology (1970) 0.82
Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: effect of aminooxyacetic acid. Neurosci Lett (1990) 0.82
Intrahippocampal bethanechol in rats: behavioural, electroencephalographic and neuropathological correlates. Behav Brain Res (1983) 0.82
The role of GABA-ergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J Exp Clin Cancer Res (2000) 0.82
The spontaneous motility of rats after intraventricular injection of dopamine. Neuropharmacology (1972) 0.82
Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur J Pharmacol (1998) 0.82
7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm (Vienna) (2006) 0.81
Synthesis and preliminary screening of derivatives of 2-(4-arylpiperazin-1-ylalkyl)-3-oxoisothiazolo[5,4-b] pyridines as CNS and antimycobacterial agents. Pharmazie (2000) 0.81
Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis. J Neural Transm (Vienna) (2007) 0.81
Central action of glucagon. Pol J Pharmacol (1999) 0.81
Behavioural effects of yohimbine administered intraventricularly in the rat. Psychopharmacologia (1973) 0.81
Effects of morphine and naloxone on pilocarpine-induced convulsions in rats. Neuropeptides (1985) 0.81
Effects of some antiepileptic drugs in pentetrazol-induced convulsions in mice lesioned with kainic acid. Epilepsia (1981) 0.81
Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.81
The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol (1995) 0.81
Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia (1993) 0.81
Effects of L-cysteine-sulphinate and L-aspartate, mixed excitatory amino acid agonists, on the membrane potential of cat caudate neurons. Brain Res (1987) 0.81
Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats. Brain Res (1988) 0.81
Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology (1992) 0.80
7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm (Vienna) (2000) 0.80
Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures. Pharmacol Biochem Behav (2001) 0.80
The central action of beta-adrenergic receptor blocking agents. I. The central action of intraventricularly administered isoprenaline in the rat. Pol J Pharmacol Pharm (1974) 0.80
Roles of group II metabotropic glutamate receptors in modulation of seizure activity. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.80
Studies on the mechanism of wet dog shakes produced by carbachol in rats. Pharmacology (1984) 0.80
Kynurenic acid: a potential pathogen in brain disorders. Ann N Y Acad Sci (1992) 0.80
Central action of some cytostatics--methotrexate (MTX) and doxorubicin (DXR). II. The influence on the seizure activity and the learning and memory processes in mice. Ann Univ Mariae Curie Sklodowska Med (1998) 0.80
Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats. Eur Neuropsychopharmacol (2001) 0.80
Evidence that antagonism at non-NMDA receptors results in anticonvulsant action. Eur J Pharmacol (1987) 0.80
Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Eur J Pharmacol (1999) 0.79